{"src_spec_res": [[{"id": "https://api.bing.microsoft.com/api/v7/#WebPages.0", "name": "The Art of <b>Creating</b> <b>New</b> <b>Medicines</b> | Pfizer", "url": "https://www.pfizer.com/art-creating-new-medicines", "isFamilyFriendly": true, "displayUrl": "https://<b>www.pfizer.com</b>/art-<b>creating</b>-<b>new</b>-<b>medicines</b>", "snippet": "And here, Owen says, designing <b>new</b> <b>medicines</b> <b>is like</b> writing music. A composer has a limited number of notes on the octave to arrange into that next hit song. Similarly, scientists can only use a few elements from the periodic table to build drugs. \u201cWe arrange these eight elements into a <b>new</b> molecule every time. There\u2019s always another great song to be written\u2014and hopefully another great molecule,\u201d he says.", "dateLastCrawled": "2022-02-03T05:50:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.1", "name": "The Pharmaceutical Industry: How Companies Develop <b>Medicines</b> - Young ...", "url": "https://www.youngpeopletoday.net/process-of-creating-medication/", "isFamilyFriendly": true, "displayUrl": "https://www.youngpeopletoday.net/process-of-<b>creating</b>-medication", "snippet": "<b>Research</b> <b>and development</b> for a <b>new</b> medicine can take decades, during which the company does not earn from it. They can spend from one to two billion dollars for every medication. This includes laboratory <b>research</b> and the need for several large clinical trials. Many of these <b>medicines</b> do not reach the market for several reasons. Some do not pass muster after laboratory tests. Some fail in the clinical trials. Among those that pass clinical trials, only about 12 percent gain FDA approval.", "dateLastCrawled": "2022-02-02T18:27:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.2", "name": "Drug discovery <b>and development</b>: Role of basic biological <b>research</b>", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725284/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC5725284", "snippet": "Here, we are considering the discovery <b>and development</b> of entirely <b>new</b> <b>medicines</b>, those with a mode of action different from already approved <b>medicines</b> and intended for a clinical indication that is not addressed by approved <b>medicines</b>. Better <b>medicines</b> that are iterative improvements on current medications are valuable as they may offer benefits over existing medications in terms of potency, safety, tolerability, or convenience, but they usually do not involve the manipulation of biological ...", "dateLastCrawled": "2022-02-02T05:52:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.3", "name": "AN OVERVIEW OF <b>NEW</b> DRUG DISCOVERY <b>AND DEVELOPMENT</b> | PharmaTutor", "url": "https://www.pharmatutor.org/articles/an-overview-of-new-drug-discovery-and-development", "isFamilyFriendly": true, "displayUrl": "https://www.pharmatutor.org/articles/an-overview-of-<b>new</b>-drug-discovery-<b>and-development</b>", "snippet": "In fact, despite the use of many <b>new</b> technologies, and the growing resources and funding for drug <b>research</b>, the number of launches of <b>new</b> <b>medicines</b> in the form of <b>new</b> molecular entities (names) has been generally decreasing for more than a decade. Clearly, the difficulty and complexity of drug <b>research</b> has increased in the past two decades. It is our aim with this article to discuss how these changes have influenced the role of medicinal chemists and to suggest ways to help them to ...", "dateLastCrawled": "2022-02-02T19:54:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.4", "name": "<b>How we research new medicines | GSK</b>", "url": "https://www.gsk.com/en-gb/research-and-development/research/how-we-research-new-medicines/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.gsk.com</b>/en-gb/<b>research</b>-<b>and-development</b>/<b>research</b>/<b>how-we-research-new-medicines</b>", "snippet": "<b>Research</b> <b>and development</b>. <b>Research</b> . <b>How we research new medicines</b>. <b>How we research new medicines</b> Our <b>research</b> focuses on science related to the immune system and human genetics, while leveraging advanced technologies including functional genomics, artificial intelligence and machine learning \u2013 all of this is driven by the multiplier effect of Science x <b>Technology</b> x Culture. <b>Creating</b> a <b>new</b> medicine is a long and rigorous process, and it can take up to 15 years to progress from a promising ...", "dateLastCrawled": "2022-02-02T09:52:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.5", "name": "<b>New</b> Technologies <b>and Development</b> Issues | <b>Research</b> and Information ...", "url": "https://ris.org.in/new-technologies-and-development-issues", "isFamilyFriendly": true, "displayUrl": "https://ris.org.in/<b>new</b>-technologies-<b>and-development</b>-issues", "snippet": "The objectives of <b>research</b> projects in the Health Sector are the following: Promote the role of Indian pharmaceutical industry in providing affordable access to quality <b>medicines</b> in developing countries ; <b>Development</b> of national policies and strategies for achieving SDG 3: ensuring healthy lives and promoting well-being for all at all ages; and Promotion of Indian Systems of Medicine domestically and globally. During the year, <b>research</b> within the above overall objectives have been carried on ...", "dateLastCrawled": "2022-01-16T11:30:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.6", "name": "Top 9 <b>New</b> <b>Technology Trends</b> for 2022 - Simplilearn.com", "url": "https://www.simplilearn.com/top-technology-trends-and-jobs-article", "isFamilyFriendly": true, "displayUrl": "https://www.simplilearn.com/top-<b>technology-trends</b>-and-jobs-article", "snippet": "8. 5G. The next <b>technology</b> trend that follows the IoT is 5G. Where 3G and 4G technologies have enabled us to browse the internet, use data driven services, increased bandwidths for streaming on Spotify or YouTube and so much more, 5G services are expected to revolutionize our lives. by enabling services that rely on advanced technologies <b>like</b> AR and VR, alongside cloud based gaming services <b>like</b> Google Stadia, NVidia GeForce Now and much more.", "dateLastCrawled": "2022-02-02T22:53:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.7", "name": "<b>How we develop new medicines</b> | <b>GSK</b>", "url": "https://www.gsk.com/en-gb/research-and-development/development/how-we-develop-new-medicines/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.gsk.com</b>/.../<b>research</b>-<b>and-development</b>/<b>development</b>/<b>how-we-develop-new-medicines</b>", "snippet": "In <b>Development</b>, we translate innovative early science - by following the data, unconstrained by therapy area or modality - into disease-specific potential <b>new</b> <b>medicines</b>. A project is handed over to our medicine <b>development</b> teams at Phase II, although our <b>Development</b> teams will start working with <b>Research</b> colleagues much earlier in the journey of a medicine. You can learn more about the phases in drug <b>development</b> on our", "dateLastCrawled": "2022-01-30T04:50:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.8", "name": "204 <b>Research</b> Topics on <b>Technology</b> &amp; Computer Science", "url": "https://custom-writing.org/blog/research-topics-on-technology-computer-science", "isFamilyFriendly": true, "displayUrl": "https://custom-writing.org/blog/<b>research</b>-topics-on-<b>technology</b>-computer-science", "snippet": "The <b>development</b> of this area allows people to cure diseases with the help of <b>new</b> <b>medicines</b>. In agriculture, more and more <b>research</b> is done on biological treatment and modifying plants. Biotechnology is even involved in the production of our groceries, household chemicals, and textiles. There are many exciting trends in biotechnology now that carry the potential of changing our world! For example, scientists are working on <b>creating</b> personalized drugs. This is feasible once they apply computer ...", "dateLastCrawled": "2022-02-03T00:15:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.9", "name": "<b>New</b> <b>technologies are accelerating drug development, bringing hope</b> to ...", "url": "https://www.elsevier.com/connect/new-technologies-are-accelerating-drug-development-bringing-hope-to-patients", "isFamilyFriendly": true, "displayUrl": "https://www.elsevier.com/connect/<b>new</b>-<b>technologies-are-accelerating-drug-development</b>...", "snippet": "It takes, on average, at least 10 years for a drug to make the journey from discovery to the marketplace at an average cost of $2.6 billion, according to a <b>new</b> study in the Journal of Health Economics, based on data from the Tufts Center for the Study of Drug <b>Development</b>. The overall cost includes not only the <b>development</b> costs for drugs that successfully made it to market, but also for the drugs that failed along the way. Today, the likelihood that a drug entering clinical testing will ...", "dateLastCrawled": "2022-01-27T23:29:00.0000000Z", "language": "en", "isNavigational": false}], [{"id": "https://api.bing.microsoft.com/api/v7/#WebPages.0", "name": "Drug discovery <b>and development</b>: Role of basic biological <b>research</b>", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725284/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC5725284", "snippet": "For potential <b>medicines</b> that are designed to be improved iterations on already approved <b>medicines</b>, the validating data are usually quite compelling and derive from the fact that other <b>medicines</b> with <b>similar</b> mechanism of action have shown efficacy. For AD, where there is no disease-modifying medicine, such validation is not available. In the search for <b>medicines</b> directed toward completely novel targets, advances in genetics, such as the Human Genome Project, have produced many potential <b>new</b> ...", "dateLastCrawled": "2022-02-02T05:52:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.1", "name": "<b>Technology</b> and the Future of Healthcare", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147743/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC4147743", "snippet": "<b>Technology</b> will advance and there will always be <b>new</b> and exciting solutions. Today we have robotic keyhole surgery, and things can only get better. We have intelligent decision aids to improve diagnosis, and they will only get better. Some people would point to the underlying drivers: <b>technology</b> is getting faster, better and smaller. Moore\u2019s Law says the speed of innovation is accelerating. The simple story is we will just enjoy the ride. However, the more complex story exposes trade-offs ...", "dateLastCrawled": "2022-02-02T07:13:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.2", "name": "<b>Increasing Access to Vaccines Through Technology Transfer</b> and Local ...", "url": "https://www.who.int/phi/publications/Increasing_Access_to_Vaccines_Through_Technology_Transfer.pdf", "isFamilyFriendly": true, "displayUrl": "https://<b>www.who.int</b>/phi/publications/<b>Increasing_Access_to_Vaccines_Through_Technology</b>...", "snippet": "R&amp;D <b>research</b> <b>and development</b> SII Serum Institute of India Ltd. WHO <b>World Health Organization</b> iv. Executive summary This report presents an overview of <b>technology</b> transfer and local production of vaccines in developing countries, and analyses emerging trends in this area and how <b>technology</b> transfer affects access to vaccines in developing countries. Immunization is considered to be one of the greatest health interventions to prevent infectious diseases. According to <b>World Health Organization</b> ...", "dateLastCrawled": "2022-02-02T16:26:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.3", "name": "<b>Pharmaceutical Production and Related Technology Transfer</b>", "url": "https://www.who.int/phi/publications/Local_production_and_access_to_medicines.pdf", "isFamilyFriendly": true, "displayUrl": "https://<b>www.who.int</b>/phi/publications/Local_production_and_access_to_<b>medicines</b>.pdf", "snippet": "R&amp;D <b>research</b> <b>and development</b> SACU Southern African Customs Unit SADC Southern African <b>Development</b> Community SAGMA Southern African Generics <b>Medicines</b> Association SIDA Swedish International <b>Development</b> Agency TB tuberculosis TRIPS WTO Agreement on Trade-Related Aspects of Intellectual Property Rights UN United Nations UNAIDS United Nations Programme on HIV/AIDS UNCTAD United Nations Conference on Trade <b>and Development</b> UNDP United Nations <b>Development</b> Programme UNFPA United Nations Population ...", "dateLastCrawled": "2022-01-30T01:31:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.4", "name": "<b>New</b> <b>technologies are accelerating drug development, bringing hope</b> to ...", "url": "https://www.elsevier.com/connect/new-technologies-are-accelerating-drug-development-bringing-hope-to-patients", "isFamilyFriendly": true, "displayUrl": "https://www.elsevier.com/connect/<b>new</b>-<b>technologies-are-accelerating-drug-development</b>...", "snippet": "<b>New</b> <b>technologies are accelerating drug development, bringing hope</b> to patients. In 2001, when Jamie was diagnosed with chronic myelogenous leukemia (CML), a cancer that starts inside the bone marrow, the disease had few effective cures. Fourteen years later, thanks to advances in cancer treatment, she is able to manage the disease and live a ...", "dateLastCrawled": "2022-01-27T23:29:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.5", "name": "<b>Creating</b> <b>medicines</b>", "url": "https://www.proqr.com/files/2021-09/ProQR%20Axiomer%20Technology%20Overview.pdf", "isFamilyFriendly": true, "displayUrl": "https://www.proqr.com/files/2021-09/ProQR Axiomer <b>Technology</b> Overview.pdf", "snippet": "<b>research</b> collaboration with Lilly Announced global licensing and <b>research</b> collaboration with Lilly on up to five targets using our proprietary Axiomer platform Focused on the discovery, <b>development</b>, and commercialization of potential <b>new</b> <b>medicines</b> for genetic disorders in the liver and nervous system ProQR to receive $50 million consisting of:", "dateLastCrawled": "2022-02-01T14:58:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.6", "name": "(PDF) <b>Creating a Science and Technology Park Model</b>", "url": "https://www.researchgate.net/publication/334574043_Creating_a_Science_and_Technology_Park_Model", "isFamilyFriendly": true, "displayUrl": "https://www.<b>research</b>gate.net/publication/334574043_<b>Creating_a_Science_and_Technology</b>...", "snippet": "Changes in available science and <b>technology</b>, as well as a number of challenges in the current system, outlined in this paper, are transforming approaches to <b>medicines</b> <b>development</b> and approval. It ...", "dateLastCrawled": "2021-12-10T23:49:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.7", "name": "Process for the <b>development</b> of <b>new</b> <b>medicines</b> and its changes", "url": "https://www.researchgate.net/publication/331770628_Process_for_the_development_of_new_medicines_and_its_changes", "isFamilyFriendly": true, "displayUrl": "https://www.<b>research</b>gate.net/publication/331770628_Process_for_the_<b>development</b>_of_<b>new</b>...", "snippet": "Download Citation | Process for the <b>development</b> of <b>new</b> <b>medicines</b> and its changes | It seems that the <b>development</b> of <b>new</b> drugs are perceived to be late in spite of the rapid advancement of the ...", "dateLastCrawled": "2021-12-11T17:44:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.8", "name": "Regulatory issues for orphan <b>medicines</b>: A review - ScienceDirect", "url": "https://www.sciencedirect.com/science/article/pii/S2211883719300796", "isFamilyFriendly": true, "displayUrl": "https://www.sciencedirect.com/science/article/pii/S2211883719300796", "snippet": "Successful <b>development</b> of <b>new</b> treatments for rare diseases and their sustainable patient access require overcoming a series of challenges related to <b>research</b> and health <b>technology</b> assessment. The orphan drugs legislation provides a set of incentives and conditions to the pharmaceutical industry to develop <b>medicines</b> for the treatment of rare diseases. In fact, the number of orphan products approved (centralized level) is far exceeding anything seen before the orphan drug legislation. However ...", "dateLastCrawled": "2022-01-30T01:15:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.9", "name": "Collaboration leverages unique StaR\u00ae <b>technology</b> and SBDD platform for ...", "url": "https://soseiheptares.com/uploads/news/id615/Highland%20PR_final%20CLEAN%201.pdf", "isFamilyFriendly": true, "displayUrl": "https://soseiheptares.com/uploads/<b>new</b>s/id615/Highland PR_final CLEAN 1.pdf", "snippet": "<b>development</b> of <b>new</b> <b>medicines</b> originating from our proprietary GPCR -targeted StaR\u00ae <b>technology</b> and structure-based drug design platform capabilities. We are advancing a broad and deep pipeline of novel <b>medicines</b> across multiple therapeutic areas, including CNS, immunooncology, - gastroenterology, inflammation, and other rare/specialty indications.", "dateLastCrawled": "2021-11-22T01:11:00.0000000Z", "language": "en", "isNavigational": false}], [{"id": "https://api.bing.microsoft.com/api/v7/#WebPages.0", "name": "Drug discovery <b>and development</b>: Role of basic biological <b>research</b>", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725284/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC5725284", "snippet": "One overall theme of our article is that the process is sufficiently long, complex, and expensive so that many biological targets must be considered for every <b>new</b> medicine eventually approved for clinical use and <b>new</b> <b>research</b> tools may be needed to investigate each <b>new</b> target. Studies that contribute to solving any of the many scientific and operational issues involved in the <b>development</b> process <b>can</b> improve the efficiency of the process. An awareness of these issues allows the early ...", "dateLastCrawled": "2022-02-02T05:52:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.1", "name": "<b>Technology</b> and the Future of Healthcare", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147743/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC4147743", "snippet": "Goldacre makes clear that pharmaceutical <b>development</b> fails scientific standards; yet <b>technology</b> <b>development</b>, such as robotics or computer system <b>development</b>, does not even aspire to the scientific standards that pharmaceutical <b>research</b> is aware it fails to reach. As Goldacre puts it, pharmaceutical R&amp;D is close to immoral; yet <b>technology</b> R&amp;D is ignorant. This is worrying for the future, as technological developments may not be adequately tested, tested without satisfactory controls, and ...", "dateLastCrawled": "2022-02-02T07:13:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.2", "name": "<b>Making technological innovation work for sustainable development</b> | <b>PNAS</b>", "url": "https://www.pnas.org/content/113/35/9682", "isFamilyFriendly": true, "displayUrl": "https://<b>www.pnas.org</b>/content/113/35/9682", "snippet": "The innovation process occurs in multifaceted \u201cinnovation systems,\u201d which <b>can</b> usefully <b>be thought</b> of as the connected set of actors and ... global investment in <b>research</b> <b>and development</b> (R&amp;D) in <b>medicines</b> for \u201cneglected diseases\u201d is inadequate because the developing country populations who bear the primary burden of such diseases lack the means to incentivize such investment . Likewise, current investment in low-carbon energy does not fully reflect the interests of future generations ...", "dateLastCrawled": "2022-01-07T23:03:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.3", "name": "Science, <b>technology</b> and innovation for sustainable <b>development</b> in the ...", "url": "https://www.un.org/en/development/desa/policy/untaskteam_undf/thinkpieces/28_thinkpiece_science.pdf", "isFamilyFriendly": true, "displayUrl": "https://<b>www.un.org</b>/en/<b>development</b>/desa/policy/untaskteam_undf/thinkpieces/28_think...", "snippet": "3 Science, <b>technology</b> and innovation for sustainable <b>development</b> in the global partnership for <b>development</b> beyond 2015 A post-2015 agenda for <b>development</b>: Ensuring", "dateLastCrawled": "2022-01-21T15:10:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.4", "name": "(PDF) <b>Creating a Science and Technology Park Model</b>", "url": "https://www.researchgate.net/publication/334574043_Creating_a_Science_and_Technology_Park_Model", "isFamilyFriendly": true, "displayUrl": "https://www.<b>research</b>gate.net/publication/334574043_<b>Creating_a_Science_and_Technology</b>...", "snippet": "Changes in available science and <b>technology</b>, as well as a number of challenges in the current system, outlined in this paper, are transforming approaches to <b>medicines</b> <b>development</b> and approval. It ...", "dateLastCrawled": "2021-12-10T23:49:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.5", "name": "<b>New</b> <b>technologies are accelerating drug development, bringing hope</b> to ...", "url": "https://www.elsevier.com/connect/new-technologies-are-accelerating-drug-development-bringing-hope-to-patients", "isFamilyFriendly": true, "displayUrl": "https://www.elsevier.com/connect/<b>new</b>-<b>technologies-are-accelerating-drug-development</b>...", "snippet": "But what researchers are learning is that by using certain technologies early in the drug-<b>development</b> process, they <b>can</b> identify issues that might cause a drug to fail early on, in many cases before the compound even goes into clinical testing. Then they <b>can</b> either modify the compound to address the issues, while maintaining the therapeutic effects, or make an early decision to no longer pursue the drug candidate, thereby averting a more expensive later stage failure. \u201cTraining a machine ...", "dateLastCrawled": "2022-01-27T23:29:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.6", "name": "Eli Lilly: Improving R&amp;D Through Open Innovation - <b>Technology</b> and ...", "url": "https://digital.hbs.edu/platform-rctom/submission/eli-lilly-improving-rd-through-open-innovation/", "isFamilyFriendly": true, "displayUrl": "https://digital.hbs.edu/platform-rctom/submission/eli-lilly-improving-rd-through-open...", "snippet": "For example, researchers <b>can</b> access proprietary design tools for <b>creating</b> and modifying molecules and other compound structures. As these structures are developed, researchers <b>can</b> choose to submit them for OIDD screening, a process that uses in silico analysis to identify compounds with the potential for commercial viability [6]. Other resources available to researchers include access to Lilly\u2019s library of proprietary compounds and remote experimentation in Lilly\u2019s automated synthesis ...", "dateLastCrawled": "2022-02-02T21:08:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.7", "name": "Physicists create <b>new</b> form of <b>light</b> - Massachusetts Institute of <b>Technology</b>", "url": "https://news.mit.edu/2018/physicists-create-new-form-light-0215", "isFamilyFriendly": true, "displayUrl": "https://<b>new</b>s.mit.edu/2018/physicists-create-<b>new</b>-form-<b>light</b>-0215", "snippet": "<b>Research</b> published in Science demonstrates the ability of photons to bind together in a way previously <b>thought</b> impossible \u2013 <b>creating</b> a <b>new</b> form of <b>light</b>. \u201cThe photon dance happens in a lab at MIT where the physicists run table-top experiments with lasers,\u201d writes Marissa Fessenden for Smithsonian.. \u201cPhotons bound together in this way <b>can</b> carry information \u2013 a quality that is useful for quantum computing.\u201d", "dateLastCrawled": "2022-02-02T11:19:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.8", "name": "<b>Creating Open Government Ecosystems: A Research and Development</b> Agenda", "url": "https://www.mdpi.com/1999-5903/4/4/900/htm", "isFamilyFriendly": true, "displayUrl": "https://www.mdpi.com/1999-5903/4/4/900/htm", "snippet": "This <b>can</b> be useful for the purpose of determining what <b>new</b> directions to take in developing a work process or <b>creating</b> a <b>new</b> <b>technology</b> service. As emphasized earlier, these ecologies are highly localized and idiosyncratic. As outsiders, Nardi and O\u2019Day used ethnographic data collection methods for their case analyses, but there seems to be no reason why insiders might not be able to use their own experiences and knowledge. Thus, applying this idea to open government ecosystems would mean ...", "dateLastCrawled": "2022-01-27T22:15:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.9", "name": "12 Innovations That Will Change Health Care in the 2020s | <b>Time</b>", "url": "https://time.com/5710295/top-health-innovations/", "isFamilyFriendly": true, "displayUrl": "https://<b>time.com</b>/5710295/top-health-innovations", "snippet": "The <b>technology</b> could open up <b>new</b> forms of rehabilitation and access for patients recovering from a stroke or amputation, as well as those with Parkinson\u2019s disease, multiple sclerosis and other ...", "dateLastCrawled": "2022-02-02T23:17:00.0000000Z", "language": "en", "isNavigational": false}], [{"id": "https://api.bing.microsoft.com/api/v7/#WebPages.0", "name": "Drug discovery <b>and development</b>: Role of basic biological <b>research</b>", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725284/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC5725284", "snippet": "One overall theme of our article is that the process is sufficiently long, complex, and expensive so that many biological targets must be considered for every <b>new</b> medicine eventually approved for clinical use and <b>new</b> <b>research</b> tools may be needed to investigate each <b>new</b> target. Studies that contribute to solving any of the many scientific and operational issues involved in the <b>development</b> process <b>can</b> improve the efficiency of the process. An awareness of these issues allows the early ...", "dateLastCrawled": "2022-02-02T05:52:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.1", "name": "The Pharmaceutical Industry: How Companies Develop <b>Medicines</b> - Young ...", "url": "https://www.youngpeopletoday.net/process-of-creating-medication/", "isFamilyFriendly": true, "displayUrl": "https://www.youngpeopletoday.net/process-of-<b>creating</b>-medication", "snippet": "<b>Research</b> <b>and development</b> for a <b>new</b> medicine <b>can</b> take decades, during which the company does not earn from it. They <b>can</b> spend from one to two billion dollars for every medication. This includes laboratory <b>research</b> and the need for several large clinical trials. Many of these <b>medicines</b> do not reach the market for several reasons. Some do not pass muster after laboratory tests. Some fail in the clinical trials. Among those that pass clinical trials, only about 12 percent gain FDA approval.", "dateLastCrawled": "2022-02-02T18:27:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.2", "name": "Advances in Vaccine <b>Technology</b> And Their Impact on Managed Care", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730064/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC2730064", "snippet": "In conjunction with <b>new</b> <b>technology</b> for vaccines, adjuvants are also needed. <b>New</b> compounds may enhance immunogenicity quantitatively, by increasing the levels of protective immune responses, and qualitatively, by eliciting responses from different arms of the immune system or by broadening the scope of covered immunogens. This advance has the potential to improve overall outcomes and achieve cost-savings by allowing lower doses to be used and, possibly, by eliminating or postponing the need ...", "dateLastCrawled": "2022-02-02T15:53:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.3", "name": "The Art of <b>Creating</b> <b>New</b> <b>Medicines</b> | Pfizer", "url": "https://www.pfizer.com/art-creating-new-medicines", "isFamilyFriendly": true, "displayUrl": "https://<b>www.pfizer.com</b>/art-<b>creating</b>-<b>new</b>-<b>medicines</b>", "snippet": "Drug design is often <b>compared</b> <b>to creating</b> a key to fit a lock. The key is the drug. And the lock is a protein\u2014an enzyme, receptor, or other target related to a disease. Scientists seek to create the perfect \u201ckey\u201d that when turned inside a \u201clock\u201d will have a desired biological effect in the body. A drug to fight cancer, for example, <b>can</b> act upon a protein that drives cancer cell growth. \u201cIf we find a way to bind to that protein and stop it from functioning, we <b>can</b> stop tumors from ...", "dateLastCrawled": "2022-02-03T05:50:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.4", "name": "The pursuit of <b>excellence in new-drug development</b> - <b>McKinsey &amp; Company</b>", "url": "https://www.mckinsey.com/industries/life-sciences/our-insights/the-pursuit-of-excellence-in-new-drug-development", "isFamilyFriendly": true, "displayUrl": "https://<b>www.mckinsey.com</b>/.../the-pursuit-of-<b>excellence-in-new-drug-development</b>", "snippet": "Reimagining R&amp;D demands transformation of the traditional approach to drug <b>development</b> to allow <b>medicines</b> to reach patients faster, reduce <b>development</b> costs, and improve insights and decision making. Five pillars form the basis of <b>development</b> excellence: patient- and healthcare-professional-centered design thinking, incorporated end-to-end from program and trial design to trial execution, approval, and launch; process redesign, both cross-functionally and within R&amp;D groups, that improves ...", "dateLastCrawled": "2022-02-02T12:09:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.5", "name": "<b>Resources On The Development Of New Medicines</b> | onlyhealth.com", "url": "http://www.onlyhealthy.com/resources-on-the-development-of-new-medicines/", "isFamilyFriendly": true, "displayUrl": "www.onlyhealthy.com/<b>resources-on-the-development-of-new-medicines</b>", "snippet": "<b>New</b> technologies and <b>research</b> are constantly <b>creating</b> <b>new</b> possibilities in the world of medicine and treatment. Join the thousands of others who are finding the cure for cancer or Parkinson\u2019s. This resource will direct you to current drug <b>development</b> <b>research</b> and clinical trials, the top pharmaceutical companies, information on how to market <b>new</b> <b>medicines</b>, and careers opportunities in the field of biotechnology and drug <b>development</b>. Sources in The Field Current <b>Research</b> The Medicine Market ...", "dateLastCrawled": "2022-01-12T03:57:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.6", "name": "Regulatory issues for orphan <b>medicines</b>: A review - ScienceDirect", "url": "https://www.sciencedirect.com/science/article/pii/S2211883719300796", "isFamilyFriendly": true, "displayUrl": "https://www.sciencedirect.com/science/article/pii/S2211883719300796", "snippet": "Successful <b>development</b> of <b>new</b> treatments for rare diseases and their sustainable patient access require overcoming a series of challenges related to <b>research</b> and health <b>technology</b> assessment. The orphan drugs legislation provides a set of incentives and conditions to the pharmaceutical industry to develop <b>medicines</b> for the treatment of rare diseases. In fact, the number of orphan products approved (centralized level) is far exceeding anything seen before the orphan drug legislation. However ...", "dateLastCrawled": "2022-01-30T01:15:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.7", "name": "Health <b>technology</b> assessment of paediatric <b>medicines</b>: European ...", "url": "https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15190", "isFamilyFriendly": true, "displayUrl": "https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15190", "snippet": "<b>Medicines</b> <b>development</b> is a complex process that requires time and effort to ensure safety, efficacy and quality. In the paediatric field, this process is more challenging because it involves a subgroup of the population that sees a considerable gap in the clinical evaluation of <b>medicines</b> when <b>compared</b> to the adult population. 1, 2 As an example, with approximately 100 million people aged under 19 years of age, children represent more than 20% of the European population. Despite this, more ...", "dateLastCrawled": "2022-02-02T23:34:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.8", "name": "<b>Roche</b> - <b>Research technologies</b>", "url": "https://www.roche.com/research_and_development/what_we_are_working_on/research_technologies.htm", "isFamilyFriendly": true, "displayUrl": "https://<b>www.roche.com</b>/<b>research</b>_<b>and_development</b>/what_we_are_working_on/<b>research</b>...", "snippet": "Enabling scientists to develop a <b>new</b> class of <b>medicines</b> against diseases that are difficult, or impossible, to target with antibodies and small molecules. more MDO. MDO means Multi-Dimensional Optimization. more Medicinal Chemistry. Medicinal Chemistry is a highly interdisciplinary key science within pharmaceutical <b>research</b>, uniquely positioned at the interface to many other scientific areas. more Metabolite Identification. Metabolite Identification deals with the potential safety issues ...", "dateLastCrawled": "2022-01-25T11:40:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.9", "name": "(PDF) Prizes <b>for Innovation of New Medicines and Vaccines</b>", "url": "https://www.researchgate.net/publication/51676366_Prizes_for_Innovation_of_New_Medicines_and_Vaccines", "isFamilyFriendly": true, "displayUrl": "https://www.<b>research</b>gate.net/publication/51676366_Prizes_for_Innovation_of_<b>New</b>...", "snippet": "Investment in <b>research</b> <b>and development</b> (R&amp;D) for <b>new</b> <b>medicines</b> is driven both by the U.S. domestic and foreign markets. 13 According to recent figures from IMS Health, a health care", "dateLastCrawled": "2022-01-07T05:47:00.0000000Z", "language": "en", "isNavigational": false}]], "gen_res": [[{"id": "https://api.bing.microsoft.com/api/v7/#WebPages.0", "name": "<b>Cybersecurity and Development</b>", "url": "https://libres.uncg.edu/ir/uncg/f/N_Kshetri_Cybersecurity_Development_2016.pdf", "isFamilyFriendly": true, "displayUrl": "https://libres.uncg.edu/ir/uncg/f/N_Kshetri_<b>Cybersecurity</b>_<b>Development</b>_2016.pdf", "snippet": "to the role of <b>cybersecurity</b>. This <b>research</b> sheds light on issues associated with the &quot;dark side&quot; of digitization in the Global South. We examine the hollowness in the Global South\u2019s digitization initiatives that is associated with a poor <b>cybersecurity</b>. The article also advances our understanding of how institutional and structural characteristics of the Global South influence <b>cybersecurity</b>. Keywords: cyber-control | cybercrime | <b>cybersecurity</b> | <b>development</b> | hollowness | institutional ...", "dateLastCrawled": "2021-09-16T14:51:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.1", "name": "(PDF) <b>Cybersecurity and Development</b> - Find and share <b>research</b>", "url": "https://www.researchgate.net/publication/313277776_Cybersecurity_and_Development", "isFamilyFriendly": true, "displayUrl": "https://www.<b>research</b>gate.net/publication/313277776_<b>Cybersecurity_and_Development</b>", "snippet": "<b>development</b> of the digital society and economy must inclu de steps to. strengthen individuals\u2019 and organizations\u2019 attention and orientation to. <b>cybersecurity</b> and enhance absorptive capacity in ...", "dateLastCrawled": "2022-01-03T22:08:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.2", "name": "<b>Teaching Your CEO about Cybersecurity: An Anatomical Analogy</b> \u2014 Early ...", "url": "https://earlyadopter.com/2017/12/06/teaching-your-ceo-about-cyber-security-an-anatomical-analogy/", "isFamilyFriendly": true, "displayUrl": "https://earlyadopter.com/.../<b>teaching-your-ceo-about-cyber-security-an-anatomical-analogy</b>", "snippet": "<b>Teaching Your CEO about Cybersecurity: An Anatomical Analogy</b> . In the past year or so, I\u2019ve been looking at all sorts of <b>technology</b> related to <b>cybersecurity</b>. Compared to most domains of IT, <b>cybersecurity</b> is a jungle of overlapping offerings. It is not easy to understand each product or how many products one might need. To help sort things out in my mind, I\u2019ve developed an <b>analogy</b> based on human anatomy to describe the capabilities that are offered by the various <b>cybersecurity</b> products ...", "dateLastCrawled": "2022-01-14T07:12:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.3", "name": "(PDF) <b>Cybersecurity</b> and the <b>Age of Privateering: A Historical Analogy</b> ...", "url": "https://www.academia.edu/15714412/Cybersecurity_and_the_Age_of_Privateering_A_Historical_Analogy", "isFamilyFriendly": true, "displayUrl": "https://www.academia.edu/15714412/<b>Cybersecurity</b>_and_the_Age_of_Privateering_A...", "snippet": "6 <b>Cybersecurity</b> and the <b>Age of Privateering: A Historical Analogy</b> Working Paper Series - No.1 effective auxiliary method to \u201cgrieve\u201d47 an enemy\u2019s commercial waterways, professional navies were able to The Sea and Cyberspace: perform more complicated and resource-intensive tasks, A Framework for Comparison such as establishing blockades on enemies\u2019 ports. This section develops a comparative framework for In cyberspace, various efforts for public recruitment are the <b>analogy</b> between the ...", "dateLastCrawled": "2021-08-18T00:10:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.4", "name": "<b>Cybersecurity and the Age of Privateering</b> - Understanding Cyber ...", "url": "https://carnegieendowment.org/2017/10/16/cybersecurity-and-age-of-privateering-pub-73418", "isFamilyFriendly": true, "displayUrl": "https://carnegieendowment.org/2017/10/16/<b>cybersecurity</b>-and-age-of-privateering-pub-73418", "snippet": "The <b>analogy</b> to privateering has elucidated some <b>cybersecurity</b> challenges. Learning from four hundred years of history allows for a rich understanding of the forces giving rise to the multiplicity of actors shaping the institution of privateering and eventually leading to its abolishment. Similarly, the forces enabling and constraining the different types of actors that are active in the <b>cybersecurity</b> space can be identified. First, actors in cyberspace have similar proximity to the state as ...", "dateLastCrawled": "2022-01-30T23:29:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.5", "name": "Putting the &quot;war&quot; in cyberwar: Metaphor, <b>analogy</b>, and <b>cybersecurity</b> ...", "url": "https://firstmonday.org/ojs/index.php/fm/article/download/3848/3270", "isFamilyFriendly": true, "displayUrl": "https://firstmonday.org/ojs/index.php/fm/article/download/3848/3270", "snippet": "Based in the belief that cyber \u201cweapons\u201d represent an unprecedented <b>development</b>, it is common to hear the argument that <b>technology</b> has run ahead of current ways of thinking about, planning for, and regulating the conduct of warfare. Former NATO Supreme Allied Commander and one\u2013time U.S. presidential candidate, General Wesley Clark, believes that cyber war exemplifies the tendency for <b>technology</b> to be \u201cahead of the law\u201d (Adhikari, 2009). Most notably, during his April 2010 ...", "dateLastCrawled": "2021-12-27T21:46:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.6", "name": "Impact of digital surge during Covid-19 pandemic: A viewpoint on ...", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280123/", "isFamilyFriendly": true, "displayUrl": "https://<b>www.ncbi.nlm.nih.gov</b>/pmc/articles/PMC7280123", "snippet": "Blockchain <b>technology</b> will become important and will entail <b>research</b> on design and regulations. Gig workers and the gig economy is likely to increase in scale, raising questions of work allocation, collaboration, motivation, and aspects of work overload and presenteeism. Workplace monitoring and technostress issues will become prominent with an increase in digital presence. Online fraud is likely to grow, along with <b>research</b> on managing security. The regulation of the internet, a key ...", "dateLastCrawled": "2022-02-03T07:16:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.7", "name": "An <b>Analogy</b> - Computing <b>Research</b> Association", "url": "https://cra.org/ccc/wp-content/uploads/sites/2/2018/08/Hager_Service.pdf", "isFamilyFriendly": true, "displayUrl": "https://cra.org/ccc/wp-content/uploads/sites/2/2018/08/Hager_Service.pdf", "snippet": "Testimony to the <b>Research</b> and <b>Technology</b> subcommittee of the Space, Science, and <b>Technology</b> committee 3. R&amp;T Subcommittee Subcommittee of Science, Space, and <b>Technology</b> The Subcommittee on <b>Research</b> and <b>Technology</b> has legislative jurisdiction and general oversight and investigative authority on all matters relating to science policy and science education \u2013 Intergovernmental mechanisms for <b>research</b> \u2013 National Science Foundation \u2013 NIST \u2013 DoT R&amp;T \u2013 DHS R&amp;T \u2013 \u2026. 4 https://science ...", "dateLastCrawled": "2021-08-30T14:14:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.8", "name": "(PDF) <b>Ethics in cybersecurity research and practice</b>", "url": "https://www.researchgate.net/publication/346786967_Ethics_in_cybersecurity_research_and_practice", "isFamilyFriendly": true, "displayUrl": "https://www.<b>research</b>gate.net/publication/346786967_Ethics_in_<b>cybersecurity</b>_<b>research</b>...", "snippet": "<b>cybersecurity</b> <b>research</b> ethics should draw from clinical <b>research</b> ethics, Tyler Moore and Richard Clayton, for instance, argue that in the event of recognizing harm arising, researchers should only ...", "dateLastCrawled": "2022-01-22T08:13:00.0000000Z", "language": "en", "isNavigational": false}, {"id": "https://api.bing.microsoft.com/api/v7/#WebPages.9", "name": "Tech <b>Analogy</b> | LinkedIn", "url": "https://in.linkedin.com/company/techanalogy", "isFamilyFriendly": true, "displayUrl": "https://in.linkedin.com/company/tech<b>analogy</b>", "snippet": "Tech <b>Analogy</b> | 3,006 followers on LinkedIn. INSPIRATION || IDEATION || INNOVATION | We are a platform that caters to STEM education. Our forum is built on the firm of working tirelessly to provide education in the fields of <b>technology</b> to every person, irrespective of their age location and status. Our motto &#39;INSPIRATION, IDEATION AND INNOVATION&#39; aren&#39;t mere words, but inspire us to keep the wheels of inventing minds rolling.", "dateLastCrawled": "2022-01-30T07:52:00.0000000Z", "language": "en", "isNavigational": false}], [], [], [], [], []], "all_bing_queries": ["+(technology research and development)  is like +(creating new medicines)", "+(technology research and development) is similar to +(creating new medicines)", "+(technology research and development) can be thought of as +(creating new medicines)", "+(technology research and development) can be compared to +(creating new medicines)", "cybersecurity +(technology research and development AND analogy)", "cybersecurity +(\"technology research and development is like\")", "cybersecurity +(\"technology research and development is similar\")", "cybersecurity +(\"just as technology research and development\")", "cybersecurity +(\"technology research and development can be thought of as\")", "cybersecurity +(\"technology research and development can be compared to\")"]}